FDA Adverse Event Malfunction Summary report: N

ACCESS® 2 IMMUNOASSAY SYSTEM

MDR report key: 2230319 · Received September 1, 2011

Report

Report Number
2122870-2011-03354
Event Type
Malfunction
Date Received
September 1, 2011
Date of Event
July 27, 2011
Report Date
August 1, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
DHA
PMA / PMN Number
K922823/A007
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). IT NEEDED TO BE REVISED TO REFLECT THAT THERE WERE NO DEATHS, SERIOUS INJURIES OR MODIFICATIONS TO PATIENT TREATMENT ASSOCIATED WITH THIS EVENT.

Additional Manufacturer Narrative · 1

SERVICE WAS NOT DISPATCHED TO THE SITE FOR THIS EVENT. BECKMAN COULTER INC. INVESTIGATION OF THIS EVENT IS ON-GOING.

Description of Event or Problem · 1

THE CUSTOMER REPORTED FAILING LEVEL 1 TOTAL HUMAN CHORIONIC GONADOTROPIN (TBHCG) QUALITY CONTROL (QC) RESULTS WERE GENERATED FROM AN ACCESS 2 IMMUNOASSAY SYSTEM IN ASSOCIATION WITH THE LOADING OF A NEW TBHCG REAGENT PACK ONTO THE INSTRUMENT. THE INSTRUMENT ASSAY LEVEL 1 QC RESULTS CONTINUED TO FAIL BY GREATER THAN 3 STANDARD DEVIATIONS UNTIL A NEW REAGENT PACK OF THE SAME LOT NUMBER WAS LOADED ON THE INSTRUMENT; AT SUCH TIME, THE INSTRUMENT ASSAY QC RESULTS AGAIN RECOVERED WITHIN THE CUSTOMER'S ESTABLISHED SPECIFICATIONS. INSTRUMENT ASSAY LEVELS 2 AND 3 QC RESULTS PASSED WITHIN ESTABLISHED QC RANGES ON ALL ATTEMPTS. NO PATIENT RESULTS WERE ASSOCIATED WITH THIS EVENT AND HENCE THERE WERE DEATHS, SERIOUS INJURIES OR MODIFICATIONS TO PATIENT TREATMENT ASSOCIATED WITH THIS EVENT.

Description of Event or Problem · 1

NO PATIENT RESULTS WERE ASSOCIATED WITH THIS EVENT AND HENCE THERE WERE NO DEATHS, SERIOUS INJURIES OR MODIFICATIONS TO PATIENT TREATMENT ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® 2 IMMUNOASSAY SYSTEM ANALYZER, CHEMISTRY DHA BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 ACCESS TOTAL SSHCG REAGENT